Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Human Psychopharmacology|June 4, 2010
Hyperprolactinemia associated with psychotropics--a reviewSubramoniam Madhusoodanan, Suprit Parida, Carolina Jimenez
Clinical Drug Investigation|April 5, 2021
The Pharmacology of Buprenorphine Microinduction for Opioid Use DisorderJoao P De Aquino, Suprit Parida, Mehmet Sofuoglu
Pharmacology, Biochemistry, and Behavior|February 26, 2025
Switching from menthol to non-menthol cigarettes does not impact acute responses to intravenous nicotineNoah R Wolkowicz, Suprit Parida, Ralitza Gueorguieva, et al.
Psychopharmacology|July 6, 2024
Pulsed nicotine infusions as a model for smoking: validating a tool to explore nicotine thresholds in humansSuprit Parida, R Ross MacLean, Ralitza Gueorguieva, et al.
Expert Review of Clinical Pharmacology|June 25, 2019
Buprenorphine treatment for opioid use disorder: recent progressSuprit Parida, Kathleen M Carroll, Ismene L Petrakis, et al.
Psychopharmacology|April 2, 2021
Threshold dose for intravenous nicotine self-administration in young adult non-dependent smokersR Ross MacLean, Elise E DeVito, Tore Eid, et al.
Experimental and Clinical Psychopharmacology|March 7, 2022
Threshold for the pleasurable effects of nicotine are lower than its reinforcing effects during self-administrationR Ross MacLean, Tore Eid, Suprit Parida, et al.
Experimental and Clinical Psychopharmacology|May 29, 2020
The effects of inhaled flavors on intravenous nicotineR Ross MacLean, Ralitza Gueorguieva, Elise E DeVito, et al.
Psychopharmacology|May 13, 2022
Development of pulsed intravenous nicotine infusions as a model for inhaled nicotine in humansJoao P De Aquino, Elise E DeVito, Catherine Xie, et al.
The American Journal on Addictions|March 3, 2026
Addressing tobacco use in the context of opioid use disorder: A systematic review of smoking cessation interventionsSuprit Parida, Victoria Ameral, Noah Wolkowicz, et al.
Pageof 2